Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Prostate Cancer

  Free Subscription


30.04.2018

1 AJR Am J Roentgenol
3 BJU Int
1 BMC Cancer
1 Cancer Res
1 Clin Cancer Res
1 Eur J Radiol
1 Eur Radiol
3 Eur Urol
3 Int J Cancer
1 Int J Oncol
1 Invest Radiol
1 J Cell Physiol
1 J Urol
3 N Engl J Med
2 PLoS One
2 Proc Natl Acad Sci U S A
1 Prog Urol
1 Prostate


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. LEE MS, Moon MH, Kim YA, Sung CK, et al
    Is Prostate Imaging Reporting and Data System Version 2 Sufficiently Discovering Clinically Significant Prostate Cancer? Per-Lesion Radiology-Pathology Correlation Study.
    AJR Am J Roentgenol. 2018 Apr 27:1-7. doi: 10.2214/AJR.17.18684.
    PubMed     Text format     Abstract available


    BJU Int

  2. BRIZMOHUN APPAYYA M, Adshead J, Ahmed HU, Allen C, et al
    National Implementation of multi-parametric MRI for prostate cancer detection - Recommendations from a UK consensus meeting.
    BJU Int. 2018 Apr 26. doi: 10.1111/bju.14361.
    PubMed     Text format     Abstract available

  3. EMBERTON M
    Has tailored, tissue-selective tumour ablation in men with prostate cancer come of age?
    BJU Int. 2018;121:676-677.
    PubMed     Text format    

  4. VENTIMIGLIA E, Briganti A, Montorsi F
    Lymph node dissection during radical prostatectomy for prostate cancer: extending the template in the right patients without increasing complications.
    BJU Int. 2018;121:677-678.
    PubMed     Text format    


    BMC Cancer

  5. KOO KC, Lee JS, Kim JW, Han KS, et al
    Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis.
    BMC Cancer. 2018;18:468.
    PubMed     Text format     Abstract available


    Cancer Res

  6. ZHANG Z, Cheng L, Li J, Farah E, et al
    Inhibition of the Wnt/beta-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate cancer.
    Cancer Res. 2018 Apr 26. pii: 0008-5472.CAN-17-3006.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. HUANG H, Wang C, Liu F, Li HZ, et al
    Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
    Clin Cancer Res. 2018 Apr 24. pii: 1078-0432.CCR-18-0461.
    PubMed     Text format     Abstract available


    Eur J Radiol

  8. AKIN-AKINTAYO O, Tade F, Mittal P, Moreno C, et al
    Prospective evaluation of fluciclovine ((18)F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.
    Eur J Radiol. 2018;102:1-8.
    PubMed     Text format     Abstract available


    Eur Radiol

  9. GHAI S, Perlis N, Lindner U, Hlasny E, et al
    Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
    Eur Radiol. 2018 Apr 25. pii: 10.1007/s00330-018-5409.
    PubMed     Text format     Abstract available


    Eur Urol

  10. HEINRICH D, Russnes KM, Oldenburg J
    Re: Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
    Eur Urol. 2018 Apr 21. pii: S0302-2838(18)30277.
    PubMed     Text format    

  11. TOUIJER K
    Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative An
    Eur Urol. 2018 Apr 21. pii: S0302-2838(18)30259.
    PubMed     Text format    

  12. WALZ J
    Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
    Eur Urol. 2018 Apr 18. pii: S0302-2838(18)30255.
    PubMed     Text format    


    Int J Cancer

  13. URBIOLA C, Santer FR, Petersson M, van der Pluijm G, et al
    Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31556.
    PubMed     Text format     Abstract available

  14. OKI R, Ito K, Suzuki R, Fujizuka Y, et al
    Long-term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population-based PSA screening.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31560.
    PubMed     Text format     Abstract available

  15. DOAT S, Marous M, Rebillard X, Tretarre B, et al
    Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31565.
    PubMed     Text format     Abstract available


    Int J Oncol

  16. CHENG L, Zang J, Dai HJ, Li F, et al
    Ubiquitin ligase CHIP functions as an oncogene and activates the AKT signaling pathway in prostate cancer.
    Int J Oncol. 2018 Apr 24. doi: 10.3892/ijo.2018.4377.
    PubMed     Text format     Abstract available


    Invest Radiol

  17. HE D, Chatterjee A, Fan X, Wang S, et al
    Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    Invest Radiol. 2018 Apr 27. doi: 10.1097/RLI.0000000000000466.
    PubMed     Text format     Abstract available


    J Cell Physiol

  18. DUSCHARLA D, Reddy Kami Reddy K, Dasari C, Bhukya S, et al
    Interleukin-6 induced overexpression of valosin-containing protein (VCP)/p97 is associated with androgen-independent prostate cancer (AIPC) progression.
    J Cell Physiol. 2018 Apr 25. doi: 10.1002/jcp.26639.
    PubMed     Text format     Abstract available


    J Urol

  19. LARSEN LK, Jakobsen JS, Abdul-Al A, Guldberg P, et al
    Noninvasive detection of high-grade prostate cancer by DNA-methylation analysis of urine cells captured by microfiltration.
    J Urol. 2018 Apr 24. pii: S0022-5347(18)43047-9. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


    N Engl J Med

  20. RODRIGUEZMORENO JF, GarciaDonas J
    Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653.
    PubMed     Text format    


  21. Metastatic Prostate Cancer.
    N Engl J Med. 2018;378:1653-1654.
    PubMed     Text format    

  22. ABATE-SHEN C
    Prostate Cancer Metastasis - Fueled by Fat?
    N Engl J Med. 2018;378:1643-1645.
    PubMed     Text format    


    PLoS One

  23. WALSH DMJ, Groarke AM, Morrison TG, Durkan G, et al
    Measuring a new facet of post traumatic growth: Development of a scale of physical post traumatic growth in men with prostate cancer.
    PLoS One. 2018;13:e0195992.
    PubMed     Text format     Abstract available

  24. CHEUNG S, Hamuro Y, Mahlich J, Nakayama M, et al
    Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data.
    PLoS One. 2018;13:e0195789.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  25. LEE JK, Bangayan NJ, Chai T, Smith BA, et al
    Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1802354115.
    PubMed     Text format     Abstract available

  26. TAKAYAMA KI, Suzuki T, Fujimura T, Takahashi S, et al
    COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1721957115.
    PubMed     Text format     Abstract available


    Prog Urol

  27. ROZET F, Hennequin C, Mongiat-Artus P, Beuzeboc P, et al
    [French CCAFU guidelines on prostate cancer: hormono-naive metastatic prostate cancer - update 2017].
    Prog Urol. 2018 Apr 18. pii: S1166-7087(18)30080.
    PubMed     Text format    


    Prostate

  28. BEYENE DA, Naab TJ, Kanarek NF, Apprey V, et al
    Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.
    Prostate. 2018 Apr 22. doi: 10.1002/pros.23537.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: